This cluster of papers focuses on the use of silymarin, a flavonolignan complex derived from milk thistle, in the treatment of liver diseases, including hepatitis and hepatocellular carcinoma. It explores silymarin's hepatoprotective and antioxidant effects, its potential as a supportive treatment in liver diseases, its role in cancer treatment and chemoprevention, as well as its pharmacokinetics and toxicity.